Gyon Technologies Capital Management, LP Cytokinetics Inc Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $579,564 - $819,871	-15,038 Reduced 74.81%	5,064 $245,000
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $682,060 - $983,389	20,102 New	20,102 $790,000
Q1 2022 May 12, 2022	SELL	$29.74 - $46.0 $397,861 - $615,388	-13,378 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $1.52 Million - $2.06 Million	-44,370 Reduced 76.83%	13,378 $610,000
Q3 2021 Nov 18, 2021	BUY	$18.54 - $35.74 $125,404 - $241,745	6,764 Added 13.27%	57,748 $2.06 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $1.01 Million - $1.38 Million	50,984 New	50,984 $1.01 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.61B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.